Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)
SCTID: 1179497009, Primitive, Active
1179497009|Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)|
- en Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen
- en Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)
- en Second dose of severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccination
- en Administration of second dose of sars-cov-2 virus-like particle antigen vaccine
- en Second dose of 2019-ncov virus-like particle antigen immunisation
- en Second dose of 2019-ncov virus-like particle antigen immunization
- en Second dose of 2019-ncov virus-like particle antigen vaccination
- en Second dose of 2019 novel coronavirus virus-like particle antigen immunisation
- en Second dose of 2019 novel coronavirus virus-like particle antigen immunization
- en Second dose of 2019 novel coronavirus virus-like particle antigen vaccination
- en Second dose of covid-19 virus-like particle antigen immunisation
- en Second dose of covid-19 virus-like particle antigen immunization
- en Second dose of covid-19 virus-like particle antigen vaccination
- en Second dose of sars-cov-2 virus-like particle antigen immunization
- en Second dose of sars-cov-2 virus-like particle antigen vaccination